Atreca

Atreca

Atreca is a biotechnology company that is ...

Other | United States of America | Access to Information |

 

Overview

Atreca is a biotechnology company applying its proprietary technology to deliver an unparalleled quantitation of the adaptive immune response, transforming the discovery and development of therapeutics, vaccines, and diagnostics in immuno-oncology, autoimmunity, and infectious disease. Their Immune Repertoire Capture™ technology determines the comprehensive, detailed structure of an immune response at high-throughput, delivering antibodies and T cell receptors (TCRs) from single cells with native pairing of heavy/light and α/β chains, with cell subtype and phenotype information. Moreover, Atreca is uniquely able to eliminate bias and sequence errors introduced by reverse transcription, PCR, and next-generation sequencing, delivering the high fidelity and sequence accuracy required for both accurate quantitation of antibody and TCR evolution and protein function.

Industry

Legal Structure

Operating Status

Employees

Other Operating

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

500 Saginaw Drive, First Floor
Redwood City, California 94063
United States of America



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.